Washington HB1413 prohibits state agencies, counties, cities, and towns from purchasing opioid overdose reversal medications from entities that have.
Washington HB1413 prohibits state agencies, counties, cities, and towns from purchasing opioid overdose reversal medications from entities that have settled claims of causing or fueling the opioid epidemic. The bill allows entities that agreed to provide these medications as part of a state settlement before September 1, 2024, to continue fulfilling their obligations. The Department of Health will maintain a public list of approved entities from which these medications can be purchased.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.